Immunovant, Inc. (IMVT)
25.92
+0.28
(+1.09%)
USD |
NASDAQ |
Feb 13, 12:45
Immunovant Free Cash Flow : -423.09M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Boston Scientific Corp. | 3.824B |
| Revvity, Inc. | 508.26M |
| Viridian Therapeutics, Inc. | -326.34M |
| Plus Therapeutics, Inc. | -15.78M |
| Nutriband, Inc. | -5.647M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -92.32M |
| Cash from Financing (Quarterly) | 564.60M |
| Free Cash Flow Per Share (Quarterly) | -0.5086 |
| Free Cash Flow to Equity (Quarterly) | -92.32M |
| Free Cash Flow to Firm (Quarterly) | -92.32M |
| Free Cash Flow Yield | -9.42% |